Funding Agreements in the Pharmaceuticals Industry

22 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Grant Agreement between [Foundation] and Cingulate Therapeutics, LLC for CTx-2103 Development
Funding Agreements
Cingulate Inc.
Pharmaceuticals
2025
Second Amendment to Funding Agreement among Dermavant Sciences GmbH, Dermavant Sciences Ltd., and NovaQuest Co-Investment Fund VIII, L.P.
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Alternative Royalty Payment Letter Agreement between Alimera Sciences, Inc. and SWK Funding LLC (June 19, 2024)
Financing Agreements
ALIMERA SCIENCES INC
Pharmaceuticals
NY
2024
Factoring Agreement between CSNK Working Capital Finance Corp. d/b/a Bay View Funding and EPI HEALTH, LLC dated December 1, 2022
Financing Agreements
Novan, Inc.
Pharmaceuticals
CA
2022
Corporate Advisory Agreement between GYB, LLC and MJ Holdings, Inc. (M&A and Funding)
Advisory Agreements
MJ Holdings, Inc.
Pharmaceuticals
2021
First Amendment to Funding Agreement between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P.
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2021
Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P. Funding Agreement (July 10, 2018)
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Libertas Participation Agreement, dated April 27, 2020, by and between the Gridiron BioNutrients, Inc. and Libertas Funding, LLC, a Connecticut Limited Liability Company
Funding Agreements
GridIron BioNutrients, Inc.
Pharmaceuticals
2020
Bridge Facility Commitment Letter, dated as of January 2, 2019, among Morgan Stanley Senior Funding, Inc., MUFG Bank, Ltd. and Bristol-Myers Squibb Company
Funding Agreements
Bristol-Myers Squibb
Pharmaceuticals
DE
2019
Funding Agreement Between Nuleaf, Inc. and Medifarm III, LLC for NuLeaf Reno Production, LLC
Funding Agreements
Terra Tech Corp.
Pharmaceuticals
NV
2017
Funding Agreement Between Nuleaf, Inc. and Medifarm III, LLC for Capital Contribution to Nuleaf Sparks Cultivation, LLC
Funding Agreements
Terra Tech Corp.
Pharmaceuticals
NV
2017
Amended and Restated Commitment Letter for Senior Secured Credit Facilities – Lannett Company, Inc. and Lending Consortium
Funding Agreements
Lannett Company, Inc.
Pharmaceuticals
NY
2015
Commitment Letter for Senior Secured Credit Facilities – Lannett Company, Inc., Morgan Stanley Senior Funding, Inc., and Royal Bank of Canada
Funding Agreements
Lannett Company, Inc.
Pharmaceuticals
NY
2015
Actavis Funding SCS $21 Billion Notes Underwriting Agreement with J.P. Morgan, Mizuho, and Wells Fargo (March 2015)
Underwriting Agreements
Allergan, plc
Pharmaceuticals
NY
2015
Funding Agreement between Ruthigen, Inc. and Oculus Innovative Sciences, Inc. dated January 31, 2014
Funding Agreements
Pulmatrix, Inc.
Pharmaceuticals
CA
2014
Funding Agreement Between Ruthigen, Inc. and Oculus Innovative Sciences, Inc. (January 31, 2014)
Funding Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2014
Second Amendment to Credit Agreement between Morgan Stanley Senior Funding, Inc. and Auxilium Pharmaceuticals, Inc.
Modification Agreements
AUXILIUM PHARMACEUTICALS INC
Pharmaceuticals
2013
Termination of Canadian Collateral Pledge Agreement between MidCap Funding III, LLC and Tribute Pharmaceuticals Canada Inc.
Pledge Agreements
Tribute Pharmaceuticals Canada Inc.
Pharmaceuticals
2013
Commitment Letter for Senior Secured Credit Facilities – Valeant Pharmaceuticals International, Biovail Corporation, Goldman Sachs, Morgan Stanley, and Jefferies
Funding Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NY
2010
Funding Agreement between The Stanley Medical Research Institute and Omeros Corporation (December 18, 2006)
Funding Agreements
OMEROS CORP
Pharmaceuticals
WA
2009
First Amendment to Funding and Royalty Agreement between Deerfield ED Corporation and VIVUS, Inc.
Funding Agreements
VIVUS INC
Pharmaceuticals
DE
2009
Research Funding and Option Agreement between The Scripps Research Institute and NeoRx Corporation
Funding Agreements
PONIARD PHARMACEUTICALS, INC.
Pharmaceuticals
2005